Injunction concerning Children's Panadol lifted

Date: 2013-09-09
Author:

The Full Court of the Federal Court of Australia has overturned a decision granting Reckitt Benckiser (Reckitt) an interlocutory injunction over the threatened supply by GlaxoSmithKline (GSK) of a syringe dispensing system with Children’s Panadol 1-5 years.1 The injunction had been granted based on alleged infringement by GSK of a patent owned by Reckitt.

Our associated firm, Herbert Smith Freehills, has written an article on the above decision: 

Injunction concerning Children's Panadol lifted: GlaxoSmithKline Australia Pty Ltd v Reckitt Benckiser Healthcare (UK) Limited [2013] FCAFC 102

 

1. A copy of the Full Court’s decision (GlaxoSmithKline Australia Pty Ltd v Reckitt Benckiser Healthcare (UK) Limited [2013] FCAFC 102) can be found here.